Azzad Asset Management’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-32,634
Closed -$548K 346
2025
Q2
$548K Sell
32,634
-680
-2% -$9.19K 0.06% 266
2025
Q1
$426K Buy
+33,314
New +$535K 0.05% 274
2024
Q4
Sell
-32,939
Closed -$753K 261
2024
Q3
$753K Buy
32,939
+12,458
+61% +$281K 0.08% 246
2024
Q2
$470K Sell
20,481
-4,609
-18% -$142K 0.06% 268
2024
Q1
$994K Buy
25,090
+6,629
+36% +$262K 0.12% 217
2023
Q4
$730K Buy
18,461
+220
+1% +$9.21K 0.09% 242
2023
Q3
$809K Buy
18,241
+788
+5% +$34.4K 0.11% 226
2023
Q2
$759K Buy
17,453
+983
+6% +$43.2K 0.1% 243
2023
Q1
$717K Buy
16,470
+524
+3% +$23.1K 0.1% 238
2022
Q4
$595K Buy
15,946
+165
+1% +$6.38K 0.09% 244
2022
Q3
$628K Buy
15,781
+189
+1% +$7K 0.06% 322
2022
Q2
$597K Buy
15,592
+55
+0.4% +$1.99K 0.06% 327
2022
Q1
$616K Buy
+15,537
New +$608K 0.09% 264

Other funds holding NRC

Azzad Asset Management's NRC Position: Q3 2025 in Review

Azzad Asset Management sold out of NRC Health Common Stock (NRC) in Q3 2025, closing a stake of 32,634 shares — an estimated $548K sold.

Azzad Asset Management first reported a position in NRC in Q1 2022 and held it in 13 quarters. The position peaked at $994K in Q1 2024. 118 funds tracked by Wall St. Rank hold NRC as of Q3 2025.

  • Azzad Asset Management reported no remaining NRC Health Common Stock position as of Q3 2025 after selling out during the quarter.
  • Azzad Asset Management sold 32,634 NRC Health Common Stock shares in Q3 2025, an estimated $548K.
  • Azzad Asset Management first reported a position in NRC Health Common Stock in Q1 2022 and held it in 13 quarters.
  • Azzad Asset Management's NRC Health Common Stock position peaked at $994K in Q1 2024.
  • 118 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2025.

Based on Azzad Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.